Trial Profile
Hepatic CT perfusion CT for the therapeutic response of sorafenib for hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Aug 2018
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Aug 2018 Status changed from active, no longer recruiting to completed.
- 23 Aug 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 22 Aug 2013 New trial record